Portal de Periódicos da CAPES

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey

2018; Oxford University Press; Volume: 73; Issue: 9 Linguagem: Inglês

10.1093/jac/dky221

1460-2091

Gaëlle Francine Tchouwa, Sabrina Eymard‐Duvernay, Amandine Cournil, Nadine Lamare, Laetitia Serrano, Christelle Butel, Silvia Bertagnolio, Eitel Mpoudi‐Ngolé, Elliot Raizes, Avelin F. Aghokeng, Sylvie Abia, Avelin F. Aghokeng, Silvia Bertagnolio, Dorothée Bessala, Christelle Butel, Corneluis Chebo, Oumarou Chifen, Amandine Cournil, John E Ebonloe, Sabrina Eymard‐Duvernay, Gaspary Fodjeu, Suzanne Izard, Brigitte Kamtie, Emmanuel Kiawi, Charles Kouam Kouam, Charles Kouanfack, Nadine Lamare, E. Mamang, Nadia Mandeng, Eyongetah Mbu, Bouba Mfokue, Jembia Mosoko, Bernard Nandjou, Mireille Mpoudi, Eitel Mpoudi‐Ngolé, Mariama Ndam, Anne Esther Njom Nlend, Batam Nlend, Cecile Nouboué, Pierrette Albertine Mbarga Omgba, Thierry Owono, Florant Oyono, Calixte Ida Penda, Elliot Raizes, Laetitia Serrano, Xavier Tchetnya, Christian Tchinou, Gaëlle Francine Tchouwa,

Pneumocystis jirovecii pneumonia detection and treatment

Pretreatment HIV drug resistance (PDR) has the potential to affect treatment outcome and mortality. We present here the first nationally representative PDR study conducted in Cameroon.